☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Innovent and Eli Lilly Present Results of P-Ib Study of Tyvyt (sintilimab) + Byvasda (biosimilar, bevacizumab) for Advanced Hepato...
January 24, 2022
Ascletis Reports First Patient Dosing in the P-III Clinical Trial of ASC40 + Bevacizumab for Treatment of Recurrent Glioblastoma
January 24, 2022
The Ultimate Guide To COVID-19 Vaccines: Before, During, And After Vaccination
January 24, 2022
Verona Pharma Reports Completion of Enrollment for Ensifentrine in P-III (ENHANCE-2) Trial to Treat COPD
January 24, 2022
Gilead’s Veklury (remdesivir) Receives the US FDA’s Approval for the Treatment of COVID-19
January 24, 2022
Alnylam Presents 18-Month Results of Vutrisiran in P-III (HELIOS-A) Study for the Treatment of hATTR Amyloidosis with Polyneuropat...
January 24, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions